Sister City is a modern hybrid-indica strain whose exact origins remain undocumented. While the strain is listed as being derived from ONYCD, no secondary parentage or specific breeder history has been publicly confirmed, leaving the full genetic background of this cultivar a matter of speculation. Because of this thin documentation, it is impossible to attribute the strain to a specific creator or breeding program, nor can its precise geographic or temporal roots be verified.

The chemical landscape of Sister City is marked by a complex, multi-layered terpene profile that likely follows the hierarchy of myrcene, caryophyllene, and ocimene, followed by pinene, nerolidol, limonene, humulene, linalool, beta-pinene, bisabolol, guaiol, camphene, eucalyptol, p-cymene, caryophyllene-oxide, and terpinolene. This extensive list suggests a nuanced aromatic profile, though one should consider this sequence an estimated order of dominance. The strain maintains an estimated THC content of approximately 24.5 percent, with negligible CBG levels, contributing to its chemical reputation.

Patients often utilize Sister City for managing pain, stress, and sleep, as the strain is known to induce states of relaxation and focus. Cultivators who choose to work with this modern hybrid-indica can anticipate a flowering period of 60 days, with the plant demonstrating a high yield potential. While the strain is suitable for both indoor and outdoor environments, it is categorized as a moderate difficulty grow. Currently, there are no recorded notable offspring associated with this variety.